BridgeMD
New treatment option for Endocarditis
Official title Interest of Parametric Positron Emission Imaging in the Diagnosis of Infections on Cardiac Valve Prosthesis
ClinicalTrials.gov ID: NCT05146180
What this study is testing
- What it's testing
- The objective of this study is to determine if early parametric positron emission computed tomography is useful to diagnose cardiac prosthetic valve infections.
- This is a blinded study.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age superior to18 years,
- Effective contraception for women of childbearing age or negative pregnancy test on the day of the exam
- Good general condition. WHO ≤ 1
- Suspicion of endocarditis on a prosthetic heart valve implanted more than 3 months ago
- Labeled polynuclear scintigraphy performed within a maximum of 15 days before positron emission computed tomography
You likely can't join if
- Presence of an active cancer in the previous three years
- Pregnancy or breastfeeding
- Poorly controlled diabetic patients
- Protected adults (under guardians or curators)
- Impossible decubitus (orthopnea, ...),
- Hypersensitivity to FDG or to one of the excipients of the radiopharmaceutical.
See the full eligibility criteria
- Age superior to18 years,
- Effective contraception for women of childbearing age or negative pregnancy test on the day of the exam
- Good general condition. WHO ≤ 1
- Suspicion of endocarditis on a prosthetic heart valve implanted more than 3 months ago
- Labeled polynuclear scintigraphy performed within a maximum of 15 days before positron emission computed tomography
- Standard positron emission computed tomography planned as part of the extension assessment
- Informed and signed consent before any specific study procedure.
- Patient affiliated to the social security system
- Presence of an active cancer in the previous three years
- Pregnancy or breastfeeding
- Poorly controlled diabetic patients
- Protected adults (under guardians or curators)
- Impossible decubitus (orthopnea, ...),
- Hypersensitivity to FDG or to one of the excipients of the radiopharmaceutical.
The study team makes the final eligibility decision.
Where it's taking place
- Rouen, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Rouen, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.